The global single-photon emission computed tomography market size was valued at 2.55 billion in 2021 and is poised to grow at a significant CAGR of 6.8% during the forecast period 2022-28. The imaging test single photon emission computed tomography (SPECT) displays how blood flows to tissues and organs. It's utilised to detect cancer, cardiovascular disease, and neurological issues, as well as diagnosis seizures, strokes, stress fractures, infections, and malignancies in the spine. It's a diagnostic nuclear imaging scan that combines computed tomography (CT) and a radioactive tracer. The tracer is radiolabelled, emitting gamma rays that the CT scanner can detect, allowing clinicians to observe how blood flows to tissues and organs.
Keonhacai88 Cam
68win
Trang Chủ Thabet
Lv88
Erwin Bewertung
Fun88 Jay
Nsh Home Services
Karen Fawcett
Xoilac Tv Trực Tiếp Bóng Đá
Madelyn Sadie